Octapharma’s Post

🌟 A groundbreaking study in Taiwan involving nearly 16,000 patients has revealed the life-saving potential of an AI alert system for high-risk ECGs. The AI system led to a 17% reduction in all-cause mortality within 90 days and a remarkable 31% decrease in mortality among high-risk patients, saving 7 lives per 100 patients. By enabling early identification and timely clinical interventions, this AI-driven approach significantly increases intensive care and reduces cardiac deaths. This innovation underscores the transformative impact of AI in healthcare. Further research will illuminate the mechanisms behind these promising outcomes. #HealthTech #AIinMedicine #Innovation #PatientCare

Join an insightful series of panels on healthcare innovation! Discover the impact of genomics in personalized medicine, lessons from the pandemic in vaccine development, and the transformative role of AI in drug development. Together, let's shape a brighter future for global health! #RGMBS2024

Clinician's Dilemma: Navigating AI and Data Challenges in Early Detection of Metabolic Health Disorders Detecting metabolic disorders like insulin resistance early is crucial to prevent irreversible physiological changes. But how can clinicians overcome challenges like unreliable AI models and the complexities of integrating subjective symptoms with objective measures? Join Vivek Narayan, co-founder of Serapath Integrative and visionary healthcare innovator, as he presents SATS (Stress Assessment Tracking System) – a groundbreaking approach that leverages AI to hypothesize early diagnosis through subjective assessments. With expertise spanning Australia, India, and the US, Vivek brings a systems-thinking approach to bridging technology and healthcare, aligning innovative strategies with impactful outcomes. 📅 Don’t miss this critical discussion at InnovatorMD Global Summit 2025! Register Now: https://lnkd.in/gy_u-ptz Uli K. Chettipally, MD., MPH., Ignacio H. Medrano, Ricardo Gaminha Pacheco, Dominique Kim, MPH, Suzy Engwall, Nila Rafiq, MD, MBA, FACP #AIinHealthcare #MetabolicDisorders #EarlyDetection #HealthcareInnovation #SATS #InnovatorMD

#Radiology, #gastroenterology, #dermatology and #pathology are all evolving extremely fast using AI innovation. How can #healthcare professionals maximize these technologies, with the human in the loop, to ensure that we achieve the best health outcomes, with #fairness and #equality at the core of it all? Let's get the regulations right! European Society of Pathology HealthAI - The Global Agency for Responsible AI in Health Ricardo Baptista Leite, M.D. #florence #responsibleai #epc2024

𝗣𝗿𝗲𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀 𝗶𝘀 𝗮 𝘄𝗼𝗿𝗱 𝘄𝗲 𝗵𝗮𝘃𝗲 𝗼𝘂𝘁𝗴𝗿𝗼𝘄𝗻. 𝗪𝗲𝗹𝗰𝗼𝗺𝗲 #𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀! According to #WHO, “Diagnostics is the most important tool for #healthcare professionals to identify diseases or health conditions, allowing for the initiation of treatment and helping to avoid complications and costly treatments for patients.” Discover with Dr. White how information technology and digitalization have made us step into the world of diagnostics: listen to Dr. Bart Gordts discussing solutions that will prepare any microbiology lab for the AI-driven future of healthcare! https://lnkd.in/dDW8V5Nm #Laboratory #Lablife #Avantgardelab #AI #IT

Pathologists from all over Europe got together in Florence, Italy, for the European Society of Pathology Congress where we discussed the exciting potential of AI in the field. Detecting diseases earlier ensuring timely access to more successful treatments was one of the highlights. We also explored how we at HealthAI - The Global Agency for Responsible AI in Health can contribute to this mission and we look forward to the next steps in these potential partnerships. #EPC2024 #ArtificialIntelligence #Health #HealthAI

How to predict long-term survival to assess eligibility for phase I trials? Recent studies presented at #ESMOTAT24 highlight the critical aspect of patient selection for early phase trials. Challenges persist as current prognostic tools may not be globally applicable. Fabrice Barlesi suggests that advancements in selection strategies could come from using modelling and artificial intelligence to analyse large databases, gaining insights into factors impacting patient survival and suitability for modern trials and novel treatments. 📌Full article available on #ESMODailyReporter: https://ow.ly/TzMx50QIhmX #CancerResearch #Immunotherapy

Join an insightful series of panels on healthcare innovation! Discover the impact of genomics in personalized medicine, lessons from the pandemic in vaccine development, and the transformative role of AI in drug development. Together, let's shape a brighter future for global health! #RGMBS2024

Join an insightful series of panels on healthcare innovation! Discover the impact of genomics in personalized medicine, lessons from the pandemic in vaccine development, and the transformative role of AI in drug development. Together, let's shape a brighter future for global health! #RGMBS2024